Coronavirus outbreak: the story so far
A SARS-like virus outbreak originating in Wuhan, China, is spreading into neighbouring Asian countries, and...
Read More...
Focus:
-
![]()
NICE cancer guidance: good news for Ibrance and Lynparza
The UK’s pricing regulator NICE decides whether new therapies are sufficiently cost-effective for NHS use....
Read More...
-
![CVD siloes Abcentra]()
No more siloes: linking rheumatology and CVD with Abcentra
Although there are evidence-based links between CVD and inflammatory conditions, and associated strong risk factors,...
Read More...
-
![Celgene acquisition]()
2019 top news stories
BMS acquires Celgene for an equity value of $74bn and GSK signs $4.2bn immunotherapy deal...
Read More...
-
![Top 5 terms on metabolic disorders November 2019]()
Metabolic Disorder Trends: Obesity leads Twitter mentions in November 2019
Pharmaceutical Technology lists the top five terms discussed in metabolic disorders in November 2019, based...
Read More...
-
![general election UK pharma]()
Conservative victory in general election best for UK pharma, Pharma Tech survey finds
Readers of Pharmaceutical Technology have been voting for which party’s victory in the UK’s upcoming...
Read More...
-
![]()
November’s top news stories
Novartis has signed a definitive agreement to acquire The Medicines Company for a total consideration...
Read More...
-
![]()
Medidata NEXT NYC: designing trial software with patients in mind
At its New York City NEXT conference, Medidata focused on the excitement surrounding its recent...
Read More...
-
![pancreatic cancer awareness immunotherapy]()
Making immunotherapy effective in pancreatic cancer
Immunotherapies have transformed treatment of cancers over the past few decades, but one cancer type...
Read More...
-
![UK General Election promises to pharma]()
UK general election 2019: what are the parties’ promises to pharma?
As the UK approaches a December election, the Liberal Democrats, Labour and the Conservatives have...
Read More...
